Tranexamic acid by the intramuscular or intravenous route for the prevention of postpartum haemorrhage in women at increased risk: a randomised placebo-controlled trial (I’M WOMAN)

Tranexamic acid by the intramuscular or intravenous route for the prevention of postpartum haemorrhage in women at increased risk: a randomised placebo-controlled trial (I’M WOMAN)

Abstract Background Postpartum haemorrhage (PPH) causes about 70,000 maternal deaths every year. Tranexamic acid (TXA) is a life-saving treatment for women with PPH. Intravenous (IV) TXA reduces deaths due to PPH by one-third when given within 3 h of childbirth. Because TXA is more effective when gi...

Full description

Bibliographic Details
Main Authors: Amy Brenner, Haleema Shakur-Still, Rizwana Chaudhri, Projestine Muganyizi, Oladapo Olayemi, Monica Arribas, Aasia Kayani, Kiran Javid, Adenike Bello, Ian Roberts, on behalf of the I’M WOMAN Trial Collaborative Group
Format: Article
Language:English
Published: BMC 2023-12-01
Series:Trials
Subjects:
Antifibrinolytic
Tranexamic acid
Postpartum haemorrhage
Clinical trial
Intramuscular
Intravenous
Online Access:https://doi.org/10.1186/s13063-023-07687-1

Internet

https://doi.org/10.1186/s13063-023-07687-1

Similar Items